Remogliflozin Attenuates Thioacetamide-Induced Nephrotoxicity: Association with Nrf2/HO-1, SIRT1/AMPK, and TLR4/NF-κB Pathway Modulation.
In this exploratory model, remogliflozin was associated with attenuation of TAA-induced renal injury and modulation of related biomarkers, and warrants further preclinical investigation in TAA-associated renal injury.